These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Thrombolytic therapy for myocardial infarction. Frei S N Engl J Med; 1998 Feb; 338(8):545; author reply 546-7. PubMed ID: 9471556 [No Abstract] [Full Text] [Related]
8. Reteplase set to enter thrombolytic market. Am J Health Syst Pharm; 1997 Jan; 54(1):12. PubMed ID: 9117779 [No Abstract] [Full Text] [Related]
9. Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome. Ho YL; Chen MF; Wu CC; Chen WJ; Lee YT Cardiology; 1996; 87(4):354-7. PubMed ID: 8793173 [TBL] [Abstract][Full Text] [Related]
10. Another coronary reperfusion regimen. Simoons ML Lancet; 1995 Aug; 346(8971):324-5. PubMed ID: 7623525 [No Abstract] [Full Text] [Related]
11. [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents]. Huber K Wien Klin Wochenschr; 2000 Sep; 112(17):742-8. PubMed ID: 11042902 [TBL] [Abstract][Full Text] [Related]
12. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
13. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
14. [Disappointments and trends]. Heinzl S Med Monatsschr Pharm; 1997 Oct; 20(10):263. PubMed ID: 9411176 [No Abstract] [Full Text] [Related]
16. [Elements of choice of thrombolytic agents in myocardial infarction]. Samama M; Brochet E; Valère PE Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):721-7. PubMed ID: 1530414 [TBL] [Abstract][Full Text] [Related]
17. Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction. Bode C; Schuler G; Nordt T; Schönermark S; Baumann H; Richardt G; Dietz R; Gurewich V; Kübler W Circulation; 1990 Mar; 81(3):907-13. PubMed ID: 2106403 [TBL] [Abstract][Full Text] [Related]
18. A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomes. Smalling RW Am J Health Syst Pharm; 1997 Nov; 54 Suppl 1():S17-22. PubMed ID: 9397233 [TBL] [Abstract][Full Text] [Related]
19. [Plasminogen activators as thrombolytic agents in myocardial infarction]. Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605 [TBL] [Abstract][Full Text] [Related]
20. [Coronary thrombolysis in patients with acute myocardial infarction]. Kambara H; Fudo T; Ono S Kokyu To Junkan; 1992 Jun; 40(6):537-47. PubMed ID: 1620990 [No Abstract] [Full Text] [Related] [Next] [New Search]